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Background: Acute illness, existing co-morbidities and surgical stress response can all contribute to
postoperative acute kidney injury (AKI) in patients undergoing major gastrointestinal surgery. The aim
of this study was prospectively to develop a pragmatic prognostic model to stratify patients according to
risk of developing AKI after major gastrointestinal surgery.
Methods: This prospective multicentre cohort study included consecutive adults undergoing elective or
emergency gastrointestinal resection, liver resection or stoma reversal in 2-week blocks over a continuous
3-month period. The primary outcome was the rate of AKI within 7 days of surgery. Bootstrap stability
was used to select clinically plausible risk factors into the model. Internal model validation was carried
out by bootstrap validation.
Results: A total of 4544 patients were included across 173 centres in the UK and Ireland. The overall
rate of AKI was 14⋅2 per cent (646 of 4544) and the 30-day mortality rate was 1⋅8 per cent (84 of 4544).
Stage 1 AKI was significantly associated with 30-day mortality (unadjusted odds ratio 7⋅61, 95 per cent c.i.
4⋅49 to 12⋅90; P< 0⋅001), with increasing odds of death with each AKI stage. Six variables were selected
for inclusion in the prognostic model: age, sex, ASA grade, preoperative estimated glomerular filtration
rate, planned open surgery and preoperative use of either an angiotensin-converting enzyme inhibitor or
an angiotensin receptor blocker. Internal validation demonstrated good model discrimination (c-statistic
0⋅65).
Discussion: Following major gastrointestinal surgery, AKI occurred in one in seven patients. This
preoperative prognostic model identified patients at high risk of postoperative AKI. Validation in an
independent data set is required to ensure generalizability.
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Introduction
Postoperative acute kidney injury (AKI) is a common com-
plication of major non-cardiac surgery, with a rate of
approximately 13 per cent1. Postoperative AKI is associated
with significantly increased risks of mortality and morbid-
ity, and long-term progression to chronic kidney disease
(CKD), even in patients whose renal function recovers to
baseline following the AKI episode2–4. It is also associated
with increased lengths of hospital stay and higher health-
care costs5, making AKI reduction an important target for
patients, clinicians and providers.
As no definitive therapy for postoperative AKI exists,
management of patients with AKI is limited to preven-
tion and supportive treatment. In the absence of novel
therapies, the key to reducing the burden of morbidity
and mortality associated with AKI is the development
of early interventions aimed at reducing incidence. The
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National Institute for Health and Care Excellence (NICE)
guidelines6 recommend assessing the risk of AKI before
patients undergo surgery. Sixteen prognostic models have
been proposed to predict postoperative AKI (Table S1,
supporting information). Most include variables of spe-
cific interest to either cardiac or liver surgery, which
are not appropriate for patients undergoing gastrointesti-
nal surgery. No previous model has been developed for
patients undergoing major gastrointestinal surgery, whose
risk of AKI may be determined by gastrointestinal-specific
variables such as use of laparoscopy.
The aim of this study was to develop a simple, repro-
ducible, prognostic model to stratify patients undergoing
major gastrointestinal surgery by their risk of postopera-
tive AKI.
Methods
The externally peer-reviewed and published protocol for
the multicentre prospective observational Outcomes After
Kidney injury in Surgery (OAKS) study was developed
by Student Audit and Research in Surgery (STARSurg),
a medical student-driven collaborative network7. The
research collaborative model has been described previ-
ously, successfully delivering a number of national cohort
studies8,9.
Study results are reported in line with the Transparent
Reporting of a multivariable prediction model for Individ-
ual Prognosis Or Diagnosis (TRIPOD) statement10. In the
UK, the South-East Scotland Research Ethics Service (ref-
erence NR/1506AB4) confirmed that ethical review was
not required, as this observational study collected only rou-
tine, non-patient-identifiable data. Individual participat-
ing UK centres were responsible for registering the study
locally as either clinical audit or service evaluation. In Ire-
land, participating centres were responsible for securing
research ethics approval locally, as required by institutional
regulations.
Inclusion criteria
Adult patients (aged 18 years or above) undergoing elective
or emergency gastrointestinal resection, liver resection,
or reversal of ileostomy or colostomy, using any operative
approach, were eligible for inclusion. Consecutive patients
were identified by local collaborators across multiple
predefined 2-week patient inclusion periods between 23
September 2015 and 18 November 2015. Patients having
repeat surgery within 30-day follow-up were considered to
have had one continuous episode starting from the index
operation.
Exclusion criteria
Patients with a previous kidney transplant were excluded, as
were those who had received any form of renal replacement
therapy in the 90 days before their operation. Patients pre-
senting with established AKI on admission to hospital were
also excluded. Patients for whom baseline renal function
(serum creatinine level) was unavailable in the 90 days pre-
ceding surgery were excluded, as were those for whom no
serum creatinine measurements were available in the first
7 postoperative days.
Primary outcome
The primary outcome of the studywas the incidence of AKI
within 7 days of the index surgery. Patients were identified
as developing AKI if they met Kidney Disease Improv-
ing Global Outcomes (KDIGO) criteria11 (26⋅5 μmol/l
increase in serum creatinine concentration within 48 h, or
a greater than 50 per cent increase in creatinine concentra-
tion from baseline within 7 days) or underwent unplanned
renal replacement therapy.
The following serum creatinine values were collected:
a preadmission value measured within 90 days preceding
the date of surgery; the first preoperative value measured
on the index admission; the last value measured on index
admission before surgery. The baseline value for identify-
ing postoperative AKI was the closest of these values to the
time of surgery that was available.
One serum creatinine value was recorded for each post-
operative day. If serum creatinine was measured more
than once daily, the test value taken closest to midday
was recorded. In accordance with KDIGO guidelines11,
if there was a decrease in serum creatinine concentration
after surgery, this lower value was adopted as the baseline
for identification of AKI on subsequent days.
Secondary outcomes
Secondary clinical outcomes were measured within or
at 30 days after surgery, and included: persistent AKI;
requirement for temporary or permanent renal replace-
ment therapy at any time; and occurrence of major com-
plications. Patients were classified as having persistent
AKI if the last postoperative serum creatinine level mea-
sured up to and including 30 days after surgery was at
least 50 per cent greater than the preoperative baseline12.
Major complications were defined as Clavien–Dindo grade
III–V complications13, which include unplanned proce-
dures under local or general anaesthesia, organ support in
an intensive care setting, stroke or death.
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Data validation
Participating sites were asked to identify voluntarily an
independent data validator who had not been involved in
the original data collection. The validators determined case
ascertainment and data accuracy rates. Case ascertainment
was evaluated by independent review of theatre logbooks,
operating lists and ward lists, to identify whether any eligi-
ble patients had been missed in the original data collection.
Estimation of data accuracy was based on validation of 12
predefined data fields (Table S2, supporting information).
The proportion of accurately submitted data fields was cal-
culated by dividing the number of correct data fields by the
total number of validated data fields.
Selection of variables
Selection of clinically plausible candidate predictors
for postoperative AKI was informed by a literature
review, supplemented by discussion and input from senior
nephrologists and surgeons. Variables that were feasible
to collect routinely before surgery across all centres were
selected (Table S3, supporting information). The Chronic
Kidney Disease Epidemiology Collaboration (CKD-EPI)
equation was used to calculate the baseline estimated
glomerular filtration rates (eGFR)14. Given the impreci-
sion of measurement of eGFR above 120ml per min per
1⋅73m2, eGFR values were bounded at this level. Surgical
procedures were classified as low, medium or high risk
according to 30-day mortality rates reported in Hospital
Episode Statistics9. Patients were split into planned open
and planned laparoscopic surgery groups. Patients whose
laparoscopic procedures were converted to open surgery
were included in the planned laparoscopic surgery group.
Statistical analysis
Testing between demographic and outcome groups was
with the χ2 test or, for continuous variables, Student’s
t test or the Kruskal–Wallis test. Analyses were carried
out in Stata® version 14 (StataCorp, College Station,
Texas, USA).
Before development of the prognostic model, three clin-
ically relevant risk groups were prespecified: a low-risk
group (risk of AKI less than 10 per cent) in which risk of
AKI was all but ruled out; a medium-risk group (risk 10–20
per cent); and a high-risk group (riskmore than 20 per cent)
in which intervention might be appropriate.
A list of clinically plausible interactions was determined
in advance of the statistical analysis. Bootstrap stability was
used to select risk factors into the model. This approach
estimates the proportion of times a risk factor would be
selected into the model if a different random sample of
patients were taken each time. Risk factor selection was car-
ried out in two stages. In the first stage backward variable
selection, with P> 0⋅150 as the threshold for exclusion,
was carried out within each bootstrap sample. Risk factors
selected using this backwards selection approach in least 70
per cent of bootstrap samples were included in a minimum
model. In the second stage additional risk factors were
added one at a time, and any that achieved P< 0⋅150 in at
least 70 per cent of bootstrap samples were then included
in the final model. Non-parametric bootstrap resampling
with 1000 bootstrap samples was again used to assess the
stability of interactions selected into the model, for all
interactions with P< 0⋅100. Interactions were added to
the model one at a time, and the criterion for selection
of interactions was P< 0⋅050 in at least 80 per cent of
bootstrap samples.
Calibration of the model was checked using plots of
observed versus predicted mortality in deciles of pre-
dicted risk. The Hosmer–Lemeshow test, together with
the size of differences between observed and predicted
risk in deciles of risk, was used to assess calibration.
The area under the receiver operating characteristic curve
(c-statistic) was used to assess discrimination of the model
within the derivation data set.
Internal model validation was carried out by bootstrap
validation. The c-statistic was estimated in the original
data, and bootstrap re-sampling was used to adjust for the
overoptimism due to validating the model with the same
data that were used to build the model.
Results
A total of 169 hospitals in the UK contributed data to
this study, representing about 70 per cent of all UK hospi-
tals providing gastrointestinal surgery15. In addition, four
hospitals in Ireland participated. Of 5745 otherwise eli-
gible patients, 230 (4⋅0 per cent) were excluded as they
were found to have AKI on admission, and 113 (2⋅0 per
cent) were excluded as data on baseline preoperative and/or
postoperative renal function were not available. Overall, a
total of 4544 patients, for whom it was possible to measure
AKI with complete data for all the risk factors considered
for inclusion in the model, were included in the analysis
(Fig. 1).
Validation of case ascertainment and data accuracy
Independent data validation was performed at 47 of the 173
participating centres. The case ascertainment rate was 90⋅7
per cent. A total of 11 124 data fields were validated within
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Patients submitted to database
n=6673
Patients once records with
ineligible pathology, procedures or
demographics removed
n=5745
Patients included in analysis
n=4544
Patients excluded n=928
 Ineligible procedure or pathology n=921
 Incomplete records n=7
Patients excluded n=1201
 AKI on admission to hospital n=230
 Preoperative and/or postoperative renal
 function not available n=113
 Patients excluded due to missing variables
 required for AKI risk factor analysis n=858
Fig. 1 Flow chart of inclusion and exclusion of patients. AKI,
acute kidney injury
927 patient records, with an overall data accuracy rate of
96⋅6 per cent.
Demographics
Overall, 51⋅7 per cent (2350 of 4544) of patients were
aged over 65 years and 55⋅3 per cent were men. Most
patients (81⋅9 per cent) underwent elective surgery, with
malignancy the commonest indication (60⋅2 per cent). Half
of included patients underwent planned open surgery and
half had planned laparoscopic surgery (49⋅9 versus 50⋅1 per
cent respectively) (Table 1).
Incidence of acute kidney injury
Some 14⋅2 per cent (646 of 4544) of patients developed
AKI within 7 days of surgery, most commonly stage 1 AKI
(438 of 646, 67⋅8 per cent). In addition, 17⋅5 per cent
(113 of 646) and 14⋅7 per cent (95 of 646) experienced
stage 2 and stage 3 AKI respectively (Table 2). The AKI
rate was similar in patients who underwent surgery for
malignancy or benign disease (14⋅9 versus 13⋅1 per cent
respectively; P= 0⋅084). The AKI rate was lower in patients
who had stoma reversal compared with that in patients
who underwent gastrointestinal resection or liver resection
(9⋅6 versus 14⋅8 versus 14⋅2 per cent respectively; P= 0⋅008).
In unadjusted analyses, patients who developed AKI were
older, more likely to be men, had a higher ASA grade, and
weremore likely to have higher-stage CKD than those who
did not develop AKI (Table 1). Among patients excluded
Table 1 Demographics of derivation cohort
All included
patients
(n=4544)
Patients
who developed
AKI (n= 646)
Age (years)
18–55 1266 (27⋅9) 107 (8⋅5)
56–65 928 (20⋅4) 119 (12⋅8)
66–75 1297 (28⋅5) 212 (16⋅3)
76–96 1053 (23⋅2) 208 (19⋅8)
Sex (M : F) 2513 : 2031 396 : 250
M 2513 (55⋅3) 396 (15⋅8)
F 2031 (44⋅7) 250 (12⋅3)
ASA grade
1 580 (12⋅8) 51 (8⋅8)
2 2498 (55⋅0) 311 (12⋅4)
3 1284 (28⋅3) 224 (17⋅4)
4–5 182 (4⋅0) 60 (33⋅0)
eGFR (ml per min per 1⋅73m2)
≥90 2022 (44⋅5) 209 (10⋅3)
60–89 1811 (39⋅9) 264 (14⋅6)
30–59 639 (14⋅1) 143 (22⋅4)
<30 72 (1⋅6) 30 (42)
Ischaemic heart disease
No 3984 (87⋅7) 529 (13⋅3)
Yes 560 (12⋅3) 117 (20⋅9)
Congestive heart failure
No 4458 (98⋅1) 629 (14⋅1)
Yes 86 (1⋅9) 17 (20)
Cerebrovascular disease
No 4326 (95⋅2) 605 (14⋅0)
Yes 218 (4⋅8) 41 (18⋅8)
Hypertension
No 2794 (61⋅5) 322 (11⋅5)
Yes 1750 (38⋅5) 324 (18⋅5)
Diabetes mellitus
No 3892 (85⋅7) 519 (13⋅3)
Yes 652 (14⋅3) 127 (19⋅5)
Malignancy
No 1807 (39⋅8) 237 (13⋅1)
Yes 2737 (60⋅2) 409 (14⋅9)
Preoperative ACEi/ARB
No 3538 (77⋅9) 447 (12⋅6)
Yes 1006 (22⋅1) 199 (19⋅8)
Preoperative transfusion
No 4401 (96⋅9) 615 (14⋅0)
Yes 143 (3⋅1) 31 (21⋅7)
Surgical urgency
Elective 3721 (81⋅9) 488 (13⋅1)
Emergency 823 (18⋅1) 158 (19⋅2)
Planned laparoscopic surgery
No 2269 (49⋅9) 369 (16⋅3)
Yes 2275 (50⋅1) 277 (12⋅2)
Surgical severity
Moderate 2864 (63⋅0) 387 (13⋅5)
High 1680 (37⋅0) 259 (15⋅4)
Values in parentheses are percentages. AKI, acute kidney injury; eGFR,
estimated glomerular filtration rate; ACEi, angiotensin-converting
enzyme inhibitor; ARB, angiotensin II receptor blocker.
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Table 2 Association between acute kidney injury, major complications (Clavien–Dindo grade III–V) and persistent acute kidney injury
AKI within 7 days of surgery (n=646)
No AKI* (n=3898)
Stage 1
(n=438)
Stage 2
(n=113)
Stage 3
(n=95) P†
30-day major complications <0⋅001
Yes 409 (10⋅5) 122 (27⋅9) 43 (38⋅1) 46 (48)
No 3484 (89⋅4) 316 (72⋅1) 70 (61⋅9) 49 (52)
Missing 5 (0⋅1) 0 (0) 0 (0) 0 (0)
30-day mortality < 0⋅001
Yes 32 (0⋅8) 26 (5⋅9) 11 (9⋅7) 15 (16)
No 3861 (99⋅1) 412 (94⋅1) 102 (90⋅3) 80 (84)
Missing 5 (0⋅1) 0 (0) 0 (0) 0 (0)
30-day persistent AKI <0⋅001
Yes 29 (0⋅7) 20 (4⋅6) 6 (5⋅3) 12 (13)
No 3169 (81⋅3) 339 (77⋅4) 81 (71⋅7) 58 (61)
Missing 700 (18⋅0) 79 (18⋅0) 26 (23⋅0) 25 (26)
Values in parentheses are percentages. *Includes patients who developed acute kidney injury (AKI) after the seventh postoperative day. †χ2 test.
from the study owing to missing AKI risk factor data, the
overall rate of AKI was 12⋅0 per cent (103 of 858).
Morbidity and mortality associated with acute
kidney injury
Few patients who developed AKI (51 of 646, 7⋅9 per cent)
required renal replacement therapy. Renal function recov-
ered in most patients who suffered AKI (482 of 520, 92⋅7
per cent) for whom 30-day creatinine data were available.
In univariable analysis, the development of stage 1 AKI
was strongly associated with both 30-day major complica-
tions (odds ratio (OR) 3⋅29, 95 per cent c.i. 2⋅61 to 4⋅15;
P< 0⋅001) and 30-day mortality (OR 7⋅61, 4⋅49 to 12⋅90;
P< 0⋅001). Major complications and mortality increased
with each AKI stage (Table 2), with the odds of death being
over 20 times greater in patients who developed stage 3
AKI (OR 22⋅62, 11⋅79 to 43⋅42; P< 0⋅001).
Selection of variables for the acute kidney injury
prognostic model
Six risk factors were included in the model for prediction
of AKI (Table 3). No interactions met the inclusion criteria.
Age was modelled as a linear variable and eGFR as a linear
plus quadratic variable. The strongest predictors of AKI
were age (70 versus 30 years: OR 0⋅51, 95 per cent c.i. 0⋅38
to 0⋅69; P< 0⋅001), ASA grade (1 versus 4–5: OR 2⋅81, 1⋅80
to 4⋅40; P< 0⋅001) and baseline eGFR (60 versus 30ml per
min per 1⋅73m2: OR 2⋅20, 1⋅74 to 2⋅79; P< 0⋅001).
Prognostic model calibration
The prognostic model was reasonably well calibrated
by deciles of risk (Fig. 2). The Hosmer–Lemeshow test
Table 3 Multivariable model for prediction of acute kidney injury
in the derivation cohort
Odds ratio P
Age (years) <0⋅001
30 0⋅51 (0⋅38, 0⋅69)
50 0⋅72 (0⋅62, 0⋅83)
70 1⋅00 (reference)
90 1⋅40 (1⋅21, 1⋅62)
Sex 0⋅002
M 1⋅00 (reference)
F 0⋅76 (0⋅63, 0⋅90)
eGFR (ml per min per 1⋅73m2) < 0⋅001
30 2⋅20 (1⋅74, 2⋅79)
60 1⋅00 (reference)
90 0⋅77 (0⋅69, 0⋅87)
120 1⋅02 (0⋅76, 1⋅36)
ASA grade <0⋅001
1 1⋅00 (reference)
2 1⋅26 (0⋅92, 1⋅73)
3 1⋅45 (1⋅03, 2⋅03)
4–5 2⋅81 (1⋅80, 4⋅40)
Planned surgical approach < 0⋅001
Open surgery 1⋅00 (reference)
Laparoscopic surgery 0⋅76 (0⋅64, 0⋅90)
Preoperative ACEi/ARB 0⋅009
No 1⋅00 (reference)
Yes 1⋅30 (1⋅07, 1⋅59)
Values in parentheses are 95 per cent confidence intervals. Age and
estimated glomerular filtration rate (eGFR) were modelled as continuous
variables; therefore odds ratios are given for a selection of values
compared with a baseline value. ACEi, angiotensin-converting enzyme
inhibitor; ARB, angiotensin II receptor blocker.
demonstrated a reasonable fit (P= 0⋅571). The absolute
difference between observed and predicted mortality was
within 1 per cent for six of the deciles, and was never
greater than 3 per cent (Fig. 2). For both age and eGFR,
the continuous lines fitted the risk of AKI well (Figs S1 and
S2, supporting information).
© 2018 The Authors. www.bjsopen.com BJS Open 2018; 2: 400–410
BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd
Prediction of acute kidney injury after major gastrointestinal surgery 405
30
35
25
20
15
R
is
k 
(%
)
10
5
5 10 15 20
Predicted risk (%)
Observed
Predicted
25 30
Fig. 2 Calibration plot of observed versus predicted risk of acute
kidney injury in deciles of predicted risk
Classification of risk
Overall, 14⋅6 per cent of patients (662 of 4544) were
identified as being at high risk of AKI (Tables S4 and S5,
supporting information). The overall observed AKI rate in
patients classified as high risk (28⋅5 per cent) was four times
greater than that in patients classified as low risk (7⋅1 per
cent). The sensitivity was 29⋅3 (95 per cent c.i. 25⋅8 to 32⋅8)
per cent, and the specificity 87⋅9 (86⋅8 to 88⋅9) per cent.
Discrimination and internal model validation
The c-statistic for discrimination, within the estimation
data, was 0⋅66 (95 per cent c.i. 0⋅64 to 0⋅68), indicating good
predictive performance. As expected given the large sample
size, the bootstrap validation c-index was similar (0⋅65).
Discussion
This study confirmed that postoperative AKI following
gastrointestinal surgery is common, affecting around one
in seven patients, and is associated with an increased risk
of major complications and death. A prognostic model to
predict a patient’s risk of developing AKI was constructed
from a large derivation cohort using six simple preoperative
variables, and found to perform well following internal
validation.
Previous studies have reported postoperative AKI rates
between 2 and 39 per cent1. This wide range reflects hetero-
geneity among their patient populations and variability in
the definitions of AKI. Most studies use either traditional
AKI definitions, such as the Acute Kidney Injury Network
(AKIN) definition or the Risk, Injury, Failure, Loss of
kidney function, and End-stage kidney disease (RIFLE)
criteria, both of which lack the sensitivity of the
newer KDIGO AKI definition11. As even ‘mild’, tran-
sient episodes of AKI captured by KDIGO definitions
are associated with increased mortality12, studies reliant
on AKIN and RIFLE definitions probably underestimate
both the incidence and burden of morbidity associated
with postoperative AKI.
The overall postoperative KDIGO AKI rate was 14⋅2
per cent. This is in line with systematic review findings1.
As in previous observational studies12,16, AKI was detected
based on renal function only, because urine output data
could not be collected reliably. Although determination
of serum creatinine level is in routine clinical use for
estimating the glomerular filtration rate, it has significant
limitations, including unpredictable responses to stress,
disease and nutrition. The initial stress response following
surgery is associated with a decrease in serum creatinine
levels12,17. This may mask the true frequency and severity
of postoperative AKI and overestimate renal recovery.
In the present cohort, AKI was associated with a signifi-
cantly increased risk of morbidity and mortality. Although
a causative relationship between AKI and poor clinical out-
comes cannot be claimed with this study design, numerous
potential mechanisms for harm exist. AKI is independently
associated with cytokine release, systemic inflammation
and organ dysfunction18,19. AKI is an independent pre-
dictor of death20, and patients who recover from AKI
remain at increased risk of cardiovascular complications,
progression of CKD and end-stage renal failure21. Recent
evidence12 suggests that even mild transient postoperative
AKI is strongly associated with an increased risk of death
for up to 1 year after surgery.
National UK guidelines mandate that risk assessment
of the likelihood of postoperative AKI should inform
patients’ clinical management6. A number of practi-
cal recommendations are made for the management of
high-risk patients, aimed at reducing the incidence of AKI
(Table S6, supporting information), with some evidence
supporting implementation of AKI prevention bundles
based on similar principles22. The prognostic model
described here identified a high-risk group in which it
would be feasible to implement interventions aimed at
mitigating AKI.
Five of the six risk factors contributing to the score
(age, sex, ASA grade, CKD stage (eGFR), ACEi/ARB
use) match the variables included in the Bell score16,
developed in a cohort of patients undergoing orthopaedic
surgery. The identification of planned open surgery as a
risk factor reflects the physiological insult and inflamma-
tory response associated with open surgery23, which may
contribute to AKI and potentiate the adverse systemic
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sequelae of AKI24. The present findings suggest that, even
if pneumoperitoneum during laparoscopic surgery reduces
renal perfusion25, this does not necessarily translate to a
greater AKI risk.
Many existing prognostic scores have focused on rare
endpoints, maximizing their performance. Four previous
prognostic models were developed to predict the need for
renal replacement therapy (Table S1, supporting informa-
tion). Given that only one in 100 patients required renal
replacement therapy, this endpoint has limited clinical sig-
nificance. The present study identified a strong association
between KDIGO AKI and mortality, even in stage 1 AKI,
underlining its clinical importance, although it is possi-
ble that the KDIGO definition picked up some transient
episodes of very mild AKI that have limited clinical signif-
icance, thus impairing the score’s discrimination.
The observational nature of this study limited the com-
plexity of candidate variables that could be collected. For
example, although simple surrogate data points such as
preoperative haemoglobin level, red cell transfusion and
anticipated intraoperative contamination were not found
to predict AKI in this study, the collection of data on pre-
operative frailty, sepsis, intraoperative fluid management,
blood loss and periods of prolonged hypotension may
have identified additional variables that predict AKI26,27.
The model’s discrimination may be limited by excluding
intraoperative variables, such as the use of vasopressors or
goal-directed fluid therapy28, and postoperative factors,
such as the development of sepsis.
To support uptake, an online calculator for patient-level
AKI risk assessment has been created (https://app.calculoid
.com/#/calculator/34162). Further external validation in an
independent data set is required.
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